The SARS-CoV-2 S-RBD IgG Antibody Rapid Test (Fingerstick Whole Blood) is a rapid chromatographic immunoassay intended for the qualitative detection of IgG antibodies to SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human Fingerstick Whole Blood approximately 10 days after vaccination. It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2. Results are for the detection of SARS-CoV-2 S-RBD IgG antibodies. Positive results indicate the presence of IgG antibodies to SARS-CoV-2.
Product Features
Fast results
Easy visual interpretation
Simple operation, no equipment required
High accuracy
PRODUCT SPECIFICATION
PrincipleChromatographic Immunoassay
FormatCassette
SpecimenFingerstick Whole Blood
CertificateCE1434
Reading Time10 minutes
Pack1/2/5/7/10/15/20/25 T
Storage Temperature2-30°C
Shelf Life2 Years
Sensitivity97.5%
Specificity99.4%
Accuracy98.2%
Ordering Information
Cat. No.ICSG-402H
ProductSARS-CoV-2 S-RBD IgG Antibody Rapid Test for Self Testing (Fingerstick Whole Blood)
